Back

Heart failure is the cancer for the heart: the prognostic importance of the new HLM classification

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Acute heart failure: treatment and prognosis Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Andrea D'Amato

Sapienza University of Rome, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Role of urinary potassium to creatinine ratio for tailoring the type of diuretic regimen in patients with acute heart failure and diuretic resistance
Doctor F. Croset (Madrid, ES)
Abstract Slides
Presentation thumbnail
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish Heart Failure Registry
Doctor P. Becher (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Impact of obstructive sleep apnea in patients undergoing left ventricular assist device implantation
Doctor N. Patel (Hartford, US)
Abstract Slides
Presentation thumbnail
Clinical, laboratory associates and prognostic significance of hypocapnia in acute heart failure. 
Mr M. Garus (Wroclaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure: treatment and prognosis

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources